Additionally, health care providers often recommend weight loss as part a broader HS treatment plan, even though it is not a cure for the condition
Notably, another important cell involved in the pathogenic process of RA is the fibroblast-like synoviocytes (FLSs), and there are more available studies that examine the effects of GLP-1RAs on FLSs
doi:10.1164/rccm.200508-1223OC Singh TD, Patial K, Vijayan VK, Ravi K
BMC Complement Altern Med 18(1):63 Peterson ME (2014) Animal models of disease: feline hyperthyroidism: an animal model for toxic nodular goiter
Approval (2017) Compounding when drugs are on FDAs drug shortages list (August 08, 2025) FDA Clarifies Policies For Compounders As National GLP-1 Supply Begins To Stabilize (April 28, 2025) FDAs concerns with unapproved GLP-1 drugs used for weight loss (September 05, 2025) Semaglutide: Double-edged Sword with Risks and Benefits (February 3, 2025)
Weight gain during semaglutide treatment often points to an addressable factor rather than a true medication failure